Skip to search formSkip to main contentSkip to account menu

PF9601N

Known as: PF 9601N, PF-9601N 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2009
2009
PF9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] confers MAO-B independent neuroprotection in ER stress-induced cell death
2009
2009
Monoamine oxidase‐B activity is not involved in the neuroinflammatory response elicited by a focal freeze brain injury
Cryolesion of the frontoparietal cortex in mice is a well‐described brain injury paradigm that results in increased astrogliosis… 
2008
2008
Anti‐apoptotic effect of Mao‐B inhibitor PF9601N [N‐(2‐propynyl)‐2‐(5‐benzyloxy‐indolyl) methylamine] is mediated by p53 pathway inhibition in MPP+‐treated SH‐SY5Y human dopaminergic cells
PF9601N [N‐(2‐propynyl) 2‐(5‐benzyloxyindol) methylamine] is a non‐amphetamine type MAO‐B inhibitor that has shown… 
2004
2004
Indolalkylamines derivatives as antioxidant and neuroprotective agents in an experimental model of Parkinson's disease.
BACKGROUND The neuroprotective effect of N-(2-propynyl)2-(5-benzyloxy-indol)methylamine (PF 9601N), a novel MAO B inhibitor, and… 
2003
2003
PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine], a new MAO-B inhibitor, attenuates MPTP-induced depletion of striatal dopamine levels in C57/BL6 mice
2003
2003
Protective effect of N‐(2‐propynyl)‐2‐(5‐benzyloxy‐indolyl) methylamine (PF 9601N), a novel MAO‐B inhibitor, on dopamine‐lesioned PC12 cultured cells
Oxidative stress may play a role in the pathogenesis of Parkinson's disease. We have standardised a new model of dopaminergic… 
2002
2002
Neuroprotective effect of the monoamine oxidase inhibitor PF 9601N [N-(2-propynyl)-2-(5-benzyloxy-indolyl) methylamine] on rat nigral neurons after 6-hydroxydopamine-striatal lesion
2000
2000
The novel type B MAO inhibitor PF9601N enhances the duration of L-DOPA-induced contralateral turning in 6-hydroxydopamine lesioned rats
Summary. The present study examined the effect of the highly potent and selective MAO B inhibitor PF9601N on L-DOPA-induced… 
2000
2000
Neuroprotective aspects of a novel MAO-B inhibitor PF9601N.
PF9601N is an acetylenic tryptamine derivative devoid of amphetamine-like properties, that behaves as suicide MAO-B inhibitor… 
2000
2000
Involvement of Ca2+ in dopamine release in striatal rat slices by PF9601N and L-deprenyl.
Rat striatal slices were incubated 1 hour in Krebs buffer with carbogen by continuous perfusion. When both MAO-B inhibitors… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)